Skip to content
healthcare.dev

Xultophy 100/3.6

NDC 0169-2911, insulin degludec and liraglutide, injection, solution, from Novo Nordisk.

Product NDC
0169-2911
Status
Listed
Labeler
Novo Nordisk
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA208583
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0169-2911 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • INSULIN DEGLUDEC100 [iU]/mL
  • LIRAGLUTIDE3.6 mg/mL

Pharmacologic classes

GLP-1 Receptor Agonist [EPC]; Glucagon-Like Peptide 1 [CS]; Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]; Insulin Analog [EPC]; Insulin [CS]

Package NDCNDC-11Package
0169-2911-15001692911155 SYRINGE, PLASTIC in 1 CARTON (0169-2911-15) / 3 mL in 1 SYRINGE, PLASTIC

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/21335fe4-d395-4501-ac2a-2f20d7520da9
  • NADAC price for package 00169291115

    GET /v1/drugs/nadac/00169291115

Use it

Look up 0169-2911 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0169-2911 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0169-2911. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.